Latest news
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $32 - MoomooMoomoo · Fri, 07 Aug 2026 18:44:55 GMTHALOZYME THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $115 FROM $95 - BitgetBitget · Fri, 07 Aug 2026 10:34:24 GMTLIGAND PHARMACEUTICALS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $358 FROM $289 - BitgetBitget · Fri, 07 Aug 2026 03:46:19 GMTLGND Maintained by HC Wainwright & Co. -- Price Target Raised to $358 - GuruFocusGuruFocus · Thu, 06 Aug 2026 21:09:37 GMTPROTAGONIST THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $167 FROM $117 - BitgetBitget · Thu, 06 Aug 2026 17:31:58 GMTORION ENERGY SYSTEMS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $30 FROM $20 - BitgetBitget · Thu, 06 Aug 2026 11:13:04 GMTDIANTHUS THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $158 FROM $130 - BitgetBitget · Thu, 06 Aug 2026 02:09:07 GMTHC Wainwright Analysts Increase Earnings Estimates for MDGL - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:20:04 GMT